← Leaderboards
Judy Lieberman
Boston Children'S Hospital
$53,446,005
Attributed
$58,037,287
Total exposure
32
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$73,960,552 · 34
By mechanism
R01$34,780,930 · 13
U19$21,645,267 · 4
P01$8,289,385 · 2
R21$3,503,199 · 7
RC4$3,304,310 · 1
R35$901,205 · 1
Top collaborators
- Ricardo Gazzinelli7 shared
- Jack L Strominger6 shared
- Hao Wu3 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseImmuneIn VivoMediatingInfectionT-LymphocyteResponseTissuesCytokineGenesPharmaceutical PreparationsApoptosisCell MembraneNatural Killer CellsImmune ResponseHiv InfectionsIn VitroCell DeathImmunityCytotoxicGranzymeMacrophagePathogen
Grant awards (111)
Effect of tumor editing on antitumor immunity$901,205
R35 · FY2025 · CA · contact PI
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity$733,069
R01 · FY2025 · CA
Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity$733,069
R01 · FY2024 · CA
Gasdermin E and pyroptosis in cancer$478,863
R01 · FY2024 · CA · contact PI
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer$196,525
R21 · FY2024 · CA · contact PI
Decidual NK response to infection$835,797
R01 · FY2023 · AI · contact PI
Gasdermin E and pyroptosis in cancer$493,985
R01 · FY2023 · CA · contact PI
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer$248,243
R21 · FY2023 · CA · contact PI
Decidual NK response to infection$835,797
R01 · FY2022 · AI · contact PI
Gasdermin E and pyroptosis in cancer$493,985
R01 · FY2022 · CA · contact PI
Decidual NK response to infection$835,797
R01 · FY2021 · AI · contact PI
Gasdermin E and pyroptosis in cancer$504,066
R01 · FY2021 · CA · contact PI
Endogenous ligand of the NK activating receptor NKp46$221,250
R21 · FY2021 · AI · contact PI
Decidual NK response to infection$835,797
R01 · FY2020 · AI · contact PI
Granzyme and Granulysin Mediated Death of Trypanosoma cruzi$626,473
R01 · FY2020 · AI · contact PI
Gasdermin E and pyroptosis in cancer$504,066
R01 · FY2020 · CA · contact PI
Granulysin, Granzymes and Perforin in Bacterial Immune Defense$442,500
R01 · FY2020 · AI · contact PI
Endogenous ligand of the NK activating receptor NKp46$265,500
R21 · FY2020 · AI · contact PI
Mechanistic elucidation of inflammasome assembly and regulation. Supplement: Testing drugs that curtail inflammasome activation to suppress SARS-CoV-2 pathogenesis$264,999
R01 · FY2020 · AI
Decidual NK response to infection$815,116
R01 · FY2019 · AI · contact PI
Granzyme and Granulysin Mediated Death of Trypanosoma cruzi$626,473
R01 · FY2019 · AI · contact PI
Granulysin, Granzymes and Perforin in Bacterial Immune Defense$442,500
R01 · FY2019 · AI · contact PI
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer$392,740
R01 · FY2019 · CA · contact PI
Killing of P. vivax infected reticulocytes by cytotoxic T cells$212,778
R21 · FY2019 · AI
Granzyme and Granulysin Mediated Death of Trypanosoma cruzi$626,473
R01 · FY2018 · AI · contact PI
Granulysin, Granzymes and Perforin in Bacterial Immune Defense$442,500
R01 · FY2018 · AI · contact PI
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer$404,888
R01 · FY2018 · CA · contact PI
Killing of P. vivax infected reticulocytes by cytotoxic T cells$271,528
R21 · FY2018 · AI
Granzyme and Granulysin Mediated Death of Trypanosoma cruzi$626,473
R01 · FY2017 · AI · contact PI
Granulysin, Granzymes and Perforin in Bacterial Immune Defense$442,500
R01 · FY2017 · AI · contact PI
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer$404,888
R01 · FY2017 · CA · contact PI
Control of placental infection by decidual NK cell secreted granulysin$216,250
R21 · FY2017 · HD
Interferon Effects on HIV Transmission in Human Models$822,004
R01 · FY2016 · AI · contact PI
Granzyme and Granulysin Mediated Death of Trypanosoma cruzi$645,723
R01 · FY2016 · AI · contact PI
Granulysin, Granzymes and Perforin in Bacterial Immune Defense$442,500
R01 · FY2016 · AI · contact PI
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer$404,888
R01 · FY2016 · CA · contact PI
Control of placental infection by decidual NK cell secreted granulysin$276,750
R21 · FY2016 · HD
Interferon Effects on HIV Transmission in Human Models$822,004
R01 · FY2015 · AI · contact PI
Aptamer-siRNA gene knockdown to treat epithelial triple negative breast cancer$403,839
R01 · FY2015 · CA · contact PI
Interferon Effects on HIV Transmission in Human Models$822,004
R01 · FY2014 · AI · contact PI
Interferon Effects on HIV Transmission in Human Models$822,004
R01 · FY2013 · AI · contact PI
CD4 aptamer-siRNA chimeras to prevent HIV transmission$766,388
R01 · FY2013 · AI · contact PI
IVIS Spectrum for In Vivo Imaging$417,993
S10 · FY2013 · OD · contact PI
Interferon Effects on HIV Transmission in Human Models$239,690
R01 · FY2013 · AI · contact PI
Interferon Effects on HIV Transmission in Human Models$469,944
R01 · FY2012 · AI · contact PI
CD4 aptamer-siRNA chimeras to prevent HIV transmission$464,793
R01 · FY2012 · AI · contact PI
CD4 aptamer-siRNA chimeras to prevent HIV transmission$401,247
R01 · FY2012 · AI · contact PI
Interferon Effects on HIV Transmission in Human Models$119,248
R01 · FY2012 · AI · contact PI
CD4 aptamer-siRNA chimeras to prevent HIV transmission$912,992
R01 · FY2011 · AI · contact PI
Role of Host miRNAs in Persistent HIV Macrophage Infection$259,875
R21 · FY2011 · AI · contact PI
Knockdown of Gene Expression in Immune Cells in Humanized Mice$2,404,025
RC4 · FY2010 · AI · contact PI
CD4 aptamer-siRNA chimeras to prevent HIV transmission$922,188
R01 · FY2010 · AI · contact PI
Knockdown of Gene Expression in Immune Cells in Humanized Mice$900,285
RC4 · FY2010 · AI · contact PI
Mechanism of perforin activity$598,172
R01 · FY2010 · AI · contact PI
Granzyme A Pathway of CTL-Mediated Cell Death$525,000
R56 · FY2010 · AI · contact PI
Role of Host miRNAs in Persistent HIV Macrophage Infection$315,000
R21 · FY2010 · AI · contact PI
An siRNA-based microbicide to prevent HIV transmission$2,049,537
U19 · FY2009 · AI · contact PI
Mechanism of perforin activity$586,616
R01 · FY2009 · AI · contact PI
In Vitro and vaginal explant studies$532,234
U19 · FY2009 · AI · contact PI
Engineered Listeria monocytogenes as an AIDS vaccine$439,819
P01 · FY2009 · AI · contact PI
Administration Core$6,377
P01 · FY2009 · AI · contact PI
An siRNA-based microbicide to prevent HIV transmission$1,871,289
U19 · FY2008 · AI · contact PI
Mechanism of perforin activity$650,834
R01 · FY2008 · AI · contact PI
Granzyme a Pathway of CTL-Mediated Cell Death$548,695
R01 · FY2008 · AI · contact PI
In Vitro and vaginal explant studies$487,421
U19 · FY2008 · AI · contact PI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM$2,556,273
U19 · FY2007 · AI · contact PI
Engineered Listeria monocytogenes as an AIDS vaccine$1,880,724
P01 · FY2007 · AI · contact PI
An siRNA-based microbicide to prevent HIV transmission$1,857,864
U19 · FY2007 · AI · contact PI
Mechanism of perforin activity$645,316
R01 · FY2007 · AI · contact PI
Granzyme a Pathway of CTL-Mediated Cell Death$543,035
R01 · FY2007 · AI · contact PI
In Vitro and vaginal explant studies$478,776
U19 · FY2007 · AI · contact PI
Biocontained ImageStream 100 Multispectral Imaging Cytometer$358,201
S10 · FY2007 · RR · contact PI
RNAi to limit kidney ischemia/reperfusion injury$40,294
R03 · FY2007 · TW · contact PI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM$2,563,314
U19 · FY2006 · AI · contact PI
An siRNA-based microbicide to prevent HIV transmission$1,861,567
U19 · FY2006 · AI · contact PI
Engineered Listeria monocytogenes as an AIDS vaccine$1,712,912
P01 · FY2006 · AI · contact PI
Mechanism of perforin activity$648,934
R01 · FY2006 · AI · contact PI
Granzyme a Pathway of CTL-Mediated Cell Death$542,969
R01 · FY2006 · AI · contact PI
In Vitro and vaginal explant studies$435,055
U19 · FY2006 · AI · contact PI
Core A - Administrative$179,188
U19 · FY2006 · AI · contact PI
RNAi to limit kidney ischemia/reperfusion injury$38,177
R03 · FY2006 · TW · contact PI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM$2,556,265
U19 · FY2005 · AI
Engineered Listeria monocytogenes as an AIDS vaccine$1,886,912
P01 · FY2005 · AI
Granzyme a Pathway of CTL-Mediated Cell Death$539,839
R01 · FY2005 · AI
CD8 CELL DYSFUNCTION IN HIV INFECTION$473,000
R01 · FY2005 · AI
Developing RNA Interference for and HIV microbicide$330,750
R21 · FY2005 · AI
RNAi to limit kidney ischemia/reperfusion injury$39,091
R03 · FY2005 · TW
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM$2,467,065
U19 · FY2004 · AI
Engineered Listeria monocytogenes as an AIDS vaccine$1,866,960
P01 · FY2004 · AI
Granzyme a Pathway of CTL-Mediated Cell Death$524,118
R01 · FY2004 · AI
CD8 CELL DYSFUNCTION IN HIV INFECTION$473,000
R01 · FY2004 · AI
Developing RNA Interference for an HIV microbicide$330,750
R21 · FY2004 · AI
RNA INTERFERENCE AS A WEAPON AGAINST BIOTERRORISM$1,749,419
U19 · FY2003 · AI
Engineered Listeria monocytogenes as an AIDS vaccine$495,681
P01 · FY2003 · AI
CD8 CELL DYSFUNCTION IN HIV INFECTION$473,000
R01 · FY2003 · AI
GRANZYME A PATHWAY IN CTL MEDIATED CELL DEATH$444,621
R01 · FY2003 · AI
PHENOTYPICALLY DEFINED CD8 T CELLS IN HIV INFECTION$433,886
R01 · FY2003 · AI
CD8 CELL DYSFUNCTION IN HIV INFECTION$473,000
R01 · FY2002 · AI
GRANZYME A PATHWAY IN CTL MEDIATED CELL DEATH$435,980
R01 · FY2002 · AI
PHENOTYPICALLY DEFINED CD8 T CELLS IN HIV INFECTION$423,235
R01 · FY2002 · AI
CLINICAL TRIAL OF ANTIVIRAL CYTOTOXIC T LYMPHOCYTE INFUSION FOR HIV-1$28,750
M01 · FY2002 · RR
Apoptosis and Immunity$2,500
R13 · FY2002 · AI
GRANZYME A PATHWAY IN CTL MEDIATED CELL DEATH$427,586
R01 · FY2001 · AI
PHENOTYPICALLY DEFINED CD8 T CELLS IN HIV INFECTION$410,910
R01 · FY2001 · AI
CLINICAL TRIAL OF ANTIVIRAL CYTOTOXIC T LYMPHOCYTE INFUSION FOR HIV-1$28,750
M01 · FY2001 · RR
CLINICAL TRIAL OF ANTIVIRAL CYTOTOXIC T LYMPHOCYTE INFUSION FOR HIV-1$28,750
M01 · FY2001 · RR
GRANZYME A PATHWAY IN CTL MEDIATED CELL DEATH$415,230
R01 · FY2000 · AI
PHENOTYPICALLY DEFINED CD8 T CELLS IN HIV INFECTION$398,941
R01 · FY2000 · AI
CLINICAL STUDIES OF THERAPORE-HIV: A T CELL VACCINE$358,000
R21 · FY2000 · AI
CD8 T CELL DYSFUNCTION IN HIV INFECTION$345,743
R01 · FY2000 · AI
CLINICAL TRIAL OF ANTIVIRAL CYTOTOXIC T LYMPHOCYTE INFUSION FOR HIV-1$28,750
M01 · FY2000 · RR